Hepatic steatosis is defined as pathologically elevated liver fat content and has many
underlying causes. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic …

Hepatic steatosis without specific causes (eg, viral infection, alcohol abuse, etc.) is called
non-alcoholic fatty liver disease (NAFLD), which ranges from non-alcoholic fatty liver (NAFL) …

Objective Non-alcoholic fatty liver disease is highly prevalent in patients with type 2 diabetes
mellitus. Studies on glucagon-like peptide-1 receptor agonists for the treatment of non …

Please see the Editorial Comment by Richard G. Barr discussing this article.
BACKGROUND. Multiple ultrasound platforms now provide quantitative measures of hepatic …

The incidence of nonalcoholic fatty liver disease (NAFLD) is growing worldwide.
Epidemiological data suggest a strong relationship between NAFLD and T2DM. This is …

Excessive liver fat (steatosis) is now the most common cause of chronic liver disease
worldwide and is an independent risk factor for cirrhosis and associated complications …

Nonalcoholic fatty liver disease, characterized by excessive accumulation of fat in the liver,
is the most common chronic liver disease worldwide. The current standard for the detection …

Since its introduction in 1980, fatty liver disease (now termed metabolic dysfunction–
associated steatotic liver disease [MASLD]) has grown in prevalence significantly …

The study of ultrasound tissue interactions in fatty livers has a long history with strong clinical
potential for assessing steatosis. Recently we proposed alternative measures of first-and …

Please see the Editorial Comment by Erica Lynn Riedesel discussing this article. To listen to
the podcast associated with this article, please select one of the following: iTunes, Google …